Petrus Trust Company LTA Takes $957,000 Position in Bruker Corporation $BRKR

Key Points

• Petrus Trust Company LTA acquired a new stake of 22,917 shares in Bruker Corporation worth approximately $957,000 during the first quarter.
• Bruker's recent quarterly earnings report indicated an EPS of $0.32, missing analysts' estimates by 1 cent, along with a revenue of $797.40 million, down 0.4% year-over-year.
• Analysts' target prices for Bruker range between $38.00 and $60.00, with a consensus rating of "Hold" and an average target price of $51.30.

Petrus Trust Company LTA purchased a new position in Bruker Corporation (NASDAQ:BRKR - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 22,917 shares of the medical research company's stock, valued at approximately $957,000.

Several other hedge funds and other institutional investors have also made changes to their positions in BRKR. CGN Advisors LLC increased its holdings in shares of Bruker by 1.4% in the first quarter. CGN Advisors LLC now owns 22,014 shares of the medical research company's stock worth $919,000 after acquiring an additional 296 shares in the last quarter. New York State Teachers Retirement System increased its holdings in shares of Bruker by 0.8% in the first quarter. New York State Teachers Retirement System now owns 37,115 shares of the medical research company's stock worth $1,549,000 after acquiring an additional 300 shares in the last quarter. State of Michigan Retirement System increased its holdings in shares of Bruker by 1.1% in the first quarter. State of Michigan Retirement System now owns 26,493 shares of the medical research company's stock worth $1,106,000 after acquiring an additional 300 shares in the last quarter. Louisiana State Employees Retirement System increased its holdings in shares of Bruker by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 31,000 shares of the medical research company's stock worth $1,294,000 after acquiring an additional 300 shares in the last quarter. Finally, KBC Group NV increased its holdings in shares of Bruker by 0.8% in the first quarter. KBC Group NV now owns 44,715 shares of the medical research company's stock worth $1,866,000 after acquiring an additional 349 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Wells Fargo & Company lowered their target price on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Bank of America lowered their target price on Bruker from $61.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Barclays lowered their target price on Bruker from $46.00 to $43.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Stifel Nicolaus set a $40.00 price target on Bruker and gave the stock a "hold" rating in a research report on Tuesday, August 5th. Finally, Jefferies Financial Group set a $60.00 price target on Bruker and gave the stock a "buy" rating in a research report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $51.30.

Bruker Stock Up 1.2%

Shares of NASDAQ BRKR traded up $0.38 during trading hours on Tuesday, hitting $31.18. The company had a trading volume of 3,078,923 shares, compared to its average volume of 4,016,232. The stock has a market capitalization of $4.73 billion, a P/E ratio of 59.96, a price-to-earnings-growth ratio of 4.28 and a beta of 1.21. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. Bruker Corporation has a 1-year low of $28.53 and a 1-year high of $72.94. The firm's 50 day moving average is $36.70 and its 200-day moving average is $39.31.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.33 by ($0.01). The company had revenue of $797.40 million during the quarter, compared to analyst estimates of $811.17 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. The company's quarterly revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.52 EPS. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, analysts expect that Bruker Corporation will post 2.69 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, September 23rd. Bruker's dividend payout ratio is presently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.